Inactive Instrument
Peregrine Pharmaceuticals Share Price Nasdaq
Stocks
US7136613046
Pharmaceuticals
| 1 day | -2.83% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 15/09/2025 | |
Richard McAvoy
DFI | Director of Finance/CFO | - | 01/06/2026 |
David Stewart
CTO | Chief Tech/Sci/R&D Officer | - | 01/11/2025 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.83% | +7.69% | - | - | 80Cr | |
| +0.35% | +1.36% | +45.38% | +140.47% | 1,28000Cr | |
| -0.13% | +1.48% | +44.67% | +90.43% | 68TCr | |
| +0.37% | +0.05% | +31.00% | +112.84% | 52TCr | |
| +0.02% | +1.52% | +39.21% | +69.76% | 39TCr | |
| -0.59% | -2.11% | +61.83% | +45.16% | 36TCr | |
| -1.29% | -1.13% | +27.54% | +58.29% | 30TCr | |
| +0.09% | -0.91% | +3.19% | +37.72% | 29TCr | |
| +0.62% | -2.17% | +38.31% | +75.12% | 25TCr | |
| -0.67% | -2.72% | +38.49% | +123.56% | 21TCr | |
| Average | -0.25% | -0.51% | +36.62% | +83.71% | 48TCr | |
| Weighted average by Cap. | +0.47% | +0.20% | +39.52% | +97.37% |
Employees
-
Sector
Pharmaceuticals
